Fractyl Health (GUTS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.55, -62.74% vs the prior close of $4.16.
- Volume 14.81M shares, 98.3x its 50-day average (heavy).
- New SEC filings: 8-K (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
GUTS slides 62.7% to $1.55, a 52-week low on 98.3x normal volume. Closed at $1.55, -62.74% vs the prior close of $4.16. Day range $1.53–$2.30, opened at $2.12.
GUTS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — GUTS slides 62.7% to $1.55, a 52-week low on 98.3x normal volume
- Closed at $1.55, -62.74% vs the prior close of $4.16. Day range $1.53–$2.30, opened at $2.12.
- Volume was 14.81M shares, 98.3x its 50-day average of 150.78K — unusually heavy trading.
- Price is -77.5% vs its 50-day average ($6.89) and -82.9% vs its 200-day average ($9.07).
- 52-week range $1.53–$29.34; today's close sits at 0% of that range, 94.7% below the 52-week high.
Oct 15, 2026 — GUTS rises 2.0% to $4.16
- Closed at $4.16, +1.96% vs the prior close of $4.08. Day range $3.92–$4.21, opened at $4.03.
- Volume was 99.60K shares, 0.7x its 50-day average of 151.19K.
- Price is -40.8% vs its 50-day average ($7.02) and -54.7% vs its 200-day average ($9.19).
- 52-week range $3.78–$29.34; today's close sits at 1% of that range, 85.8% below the 52-week high.
Oct 14, 2026 — GUTS rises 1.4% to $4.08
- Closed at $4.08, +1.37% vs the prior close of $4.03. Day range $3.78–$4.21, opened at $4.05.
- Volume was 197.30K shares, 1.3x its 50-day average of 148.42K.
- Price is -42.6% vs its 50-day average ($7.10) and -56.2% vs its 200-day average ($9.31).
- 52-week range $3.78–$29.34; today's close sits at 1% of that range, 86.1% below the 52-week high.
Oct 13, 2026 — GUTS slides 8.7% to $4.03, a 52-week low
- Closed at $4.03, -8.73% vs the prior close of $4.41. Day range $4.00–$4.50, opened at $4.46.
- Volume was 220.80K shares, 1.5x its 50-day average of 145.10K.
- Price is -44.0% vs its 50-day average ($7.19) and -57.3% vs its 200-day average ($9.43).
- 52-week range $4.00–$29.34; today's close sits at 0% of that range, 86.3% below the 52-week high.
Oct 12, 2026 — GUTS ends flat (-0.2%) to $4.41
- Closed at $4.41, -0.23% vs the prior close of $4.42. Day range $4.35–$4.58, opened at $4.41.
- Volume was 134.60K shares, 0.9x its 50-day average of 143.45K.
- Price is -39.3% vs its 50-day average ($7.27) and -53.8% vs its 200-day average ($9.54).
- 52-week range $4.14–$29.34; today's close sits at 1% of that range, 85.0% below the 52-week high.
Oct 9, 2026 — GUTS jumps 4.5% to $4.42
- Closed at $4.42, +4.49% vs the prior close of $4.23. Day range $4.20–$4.55, opened at $4.21.
- Volume was 197.90K shares, 1.4x its 50-day average of 140.72K.
- Price is -39.8% vs its 50-day average ($7.34) and -54.2% vs its 200-day average ($9.66).
- 52-week range $4.14–$29.34; today's close sits at 1% of that range, 84.9% below the 52-week high.
Oct 8, 2026 — GUTS slides 6.4% to $4.23, a 52-week low on 2.2x normal volume
- Closed at $4.23, -6.42% vs the prior close of $4.52. Day range $4.14–$4.53, opened at $4.50.
- Volume was 300.50K shares, 2.2x its 50-day average of 136.85K — unusually heavy trading.
- Price is -43.0% vs its 50-day average ($7.42) and -56.7% vs its 200-day average ($9.77).
- 52-week range $4.14–$29.34; today's close sits at 0% of that range, 85.6% below the 52-week high.
Oct 7, 2026 — GUTS dips 1.1% to $4.52, a 52-week low
- Closed at $4.52, -1.09% vs the prior close of $4.57. Day range $4.43–$4.73, opened at $4.53.
- Volume was 102.30K shares, 0.7x its 50-day average of 139.33K.
- Price is -39.8% vs its 50-day average ($7.50) and -54.3% vs its 200-day average ($9.88).
- 52-week range $4.33–$29.34; today's close sits at 1% of that range, 84.6% below the 52-week high.
Oct 6, 2026 — GUTS ends flat (+0.2%) to $4.57
- Closed at $4.57, +0.22% vs the prior close of $4.56. Day range $4.40–$4.75, opened at $4.56.
- Volume was 156.70K shares, 1.1x its 50-day average of 138.89K.
- Price is -39.8% vs its 50-day average ($7.59) and -54.3% vs its 200-day average ($10.00).
- 52-week range $4.33–$29.34; today's close sits at 1% of that range, 84.4% below the 52-week high.
Oct 5, 2026 — GUTS slides 6.6% to $4.56, a 52-week low on 2.1x normal volume
- Closed at $4.56, -6.63% vs the prior close of $4.88. Day range $4.33–$4.82, opened at $4.80.
- Volume was 287.30K shares, 2.1x its 50-day average of 136.09K — unusually heavy trading.
- Price is -40.7% vs its 50-day average ($7.69) and -54.9% vs its 200-day average ($10.10).
- 52-week range $4.33–$29.34; today's close sits at 1% of that range, 84.5% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — GUTS slides 9.6% to $4.88, a 6-month low on 1.9x normal volume
- Closed at $4.88, -9.56% vs the prior close of $5.40. Day range $4.80–$5.40, opened at $5.38.
- Volume was 254.82K shares, 1.9x its 50-day average of 134.73K — unusually heavy trading.
- Price is -37.2% vs its 50-day average ($7.78) and -52.2% vs its 200-day average ($10.21).
- 52-week range $4.52–$29.34; today's close sits at 1% of that range, 83.4% below the 52-week high.
GUTS latest news & SEC filings
Every SEC filing by or about GUTS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Oct 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Sep 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Sep 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bradley William bought 64,516 shares at $0.62 (≈$39.90K) on Sep 14, 2026; now holds 149,138
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Aug 24, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 14, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Aug 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$25.54M (prior year -$27.89M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.16 (prior year -$0.57) (loss narrowed vs Jun 30, 2025)
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade GUTS
- Last results release: Aug 10, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 24, 2026, Jan 5, 2026. Based on that rhythm, the next report is likely around Nov 9, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 8.28% (largest 62.7%). That is a volatile stock.
- Liquidity: about 930.33K shares (≈$1.44M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.55 vs a range of $1.53–$29.34 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:12 on Oct 5, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: William Bradley bought 64,516 shares on Sep 14, 2026.
- Latest filings: 8-K Oct 16, 2026; 8-K Oct 1, 2026; 8-K Sep 24, 2026.
- Share count: 159.18M shares outstanding (Aug 4, 2026), +216.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
GUTS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.12 | 2.30 | 1.53 | 1.55 | 14.81M |
| Oct 15, 2026 | 4.03 | 4.21 | 3.92 | 4.16 | 99.60K |
| Oct 14, 2026 | 4.05 | 4.21 | 3.78 | 4.08 | 197.30K |
| Oct 13, 2026 | 4.46 | 4.50 | 4.00 | 4.03 | 220.80K |
| Oct 12, 2026 | 4.41 | 4.58 | 4.35 | 4.41 | 134.60K |
| Oct 9, 2026 | 4.21 | 4.55 | 4.20 | 4.42 | 197.90K |
| Oct 8, 2026 | 4.50 | 4.53 | 4.14 | 4.23 | 300.50K |
| Oct 7, 2026 | 4.53 | 4.73 | 4.43 | 4.52 | 102.30K |
| Oct 6, 2026 | 4.56 | 4.75 | 4.40 | 4.57 | 156.70K |
| Oct 5, 2026 | 4.80 | 4.82 | 4.33 | 4.56 | 287.30K |
| Oct 2, 2026 | 5.38 | 5.40 | 4.80 | 4.88 | 254.82K |
| Oct 1, 2026 | 6.00 | 6.17 | 5.10 | 5.40 | 462.33K |
| Sep 30, 2026 | 6.48 | 7.00 | 6.12 | 6.53 | 179.09K |
| Sep 29, 2026 | 5.63 | 6.26 | 5.54 | 6.24 | 139.71K |
| Sep 28, 2026 | 5.81 | 5.81 | 5.46 | 5.65 | 116.13K |
| Sep 25, 2026 | 5.82 | 5.99 | 5.34 | 5.83 | 271.46K |
| Sep 24, 2026 | 5.66 | 5.83 | 5.40 | 5.64 | 128.68K |
| Sep 23, 2026 | 6.62 | 6.71 | 5.47 | 5.83 | 393.88K |
| Sep 22, 2026 | 6.96 | 7.20 | 6.56 | 6.64 | 92.67K |
| Sep 21, 2026 | 7.56 | 7.56 | 6.85 | 6.86 | 56.57K |
About Fractyl Health
Fractyl Health (GUTS) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in BURLINGTON, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1572616.
GUTS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| William Bradley | Director | Sep 16, 2026 |
| Kelly Ann Barnes | Director | Jun 11, 2026 |
| Samuel Conaway | Director | Jun 11, 2026 |
| Marc Elia | Director | Jun 11, 2026 |
| Clive Meanwell | Director | Jun 11, 2026 |
| Harith Rajagopalan | Chief Executive Officer | Jun 11, 2026 |
| Ajay Royan | Director | Jun 15, 2026 |
| Ian Sheffield | Director | Jun 11, 2026 |
| Christopher Charles Thompson | Director | Jun 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jay David Caplan | President, Chief Product Off. | Dec 17, 2025 |
| Harith Rajagopalan | Chief Executive Officer | Jun 11, 2026 |
| Weber Lara Smith | Chief Financial Officer | Jun 9, 2026 |
| Sarah Toomey | General Counsel | Dec 17, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 14, 2026 | William Bradley | Buy | 64,516 | $0.62 |
| Sep 14, 2026 | William Bradley | Buy | 64,516 | $0.62 |
| Sep 14, 2026 | William Bradley | Buy | 64,516 | $0.62 |
| Sep 14, 2026 | William Bradley | Buy | 64,516 | $0.62 |
| Jun 12, 2026 | Ajay Royan | Buy | 23,000 | $0.85 |
| Jun 12, 2026 | Ajay Royan | Buy | 23,000 | $0.85 |
| Jun 12, 2026 | Ajay Royan | Buy | 23,000 | $0.85 |
| Jun 12, 2026 | Ajay Royan | Buy | 23,000 | $0.85 |
| Jun 10, 2026 | Ian Sheffield | Buy | 35,000 | $0.73 |
| Jun 10, 2026 | Ian Sheffield | Buy | 35,000 | $0.73 |
| Jun 10, 2026 | Ian Sheffield | Buy | 35,000 | $0.73 |
| Jun 10, 2026 | Ian Sheffield | Buy | 35,000 | $0.73 |
| Jun 10, 2026 | Harith Rajagopalan | Buy | 25,000 | $0.73 |
| Jun 10, 2026 | Harith Rajagopalan | Buy | 25,000 | $0.73 |
| Jun 10, 2026 | Harith Rajagopalan | Buy | 25,000 | $0.73 |
GUTS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-140.95M | -1.86 | $-90.33M |
| Dec 31, 2024 | — | $-68.69M | -1.62 | $-65.52M |
| Dec 31, 2023 | — | $-77.09M | -45.29 | $-42.82M |
Latest balance sheet: total assets $81.98M, total liabilities $83.64M, cash $47.14M (as of Jun 30, 2026).
GUTS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 10, 2026 | 8-K Item 2.02 (results) | $8.10 |
| May 12, 2026 | 8-K Item 2.02 (results) | $8.81 |
| Mar 24, 2026 | 8-K Item 2.02 (results) | $5.16 |
| Jan 5, 2026 | 8-K Item 2.02 (results) | $24.72 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $13.56 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $11.81 |
| May 13, 2025 | 8-K Item 2.02 (results) | $21.24 |
| Mar 3, 2025 | 8-K Item 2.02 (results) | $18.72 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $29.16 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
| Apr 1, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on GUTS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.